User profiles for Giuseppe Vittorio De Socio

Giuseppe Vittorio De Socio

Clinica di Malattie Infettive, Azienda Ospedaliero-Universitaria di Perugia. Ospedale "Santa …
Verified email at ospedale.perugia.it
Cited by 3345

Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection

…, GV De Socio, S Sabbatini, D Francisci - Infectious …, 2020 - Taylor & Francis
Background: From January 2020, Coronavirus disease 19 (COVID-19) has rapidly spread
all over the world. An early assessment of illness severity is important for the stratification of …

Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical …

…, G Tiseo, A Bartoloni, GV De Socio… - JAMA network …, 2021 - jamanetwork.com
Importance Convalescent plasma (CP) has been generally unsuccessful in preventing
worsening of respiratory failure or death in hospitalized patients with COVID-19 pneumonia. …

Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study

GV De Socio, E Ricci, P Maggi, G Parruti… - American journal of …, 2014 - academic.oup.com
BACKGROUND We aimed to assess the prevalence of hypertension in an unselected human
immunodeficiency virus (HIV)–infected population and to identify factors associated with …

Weight gain: a possible side effect of all antiretrovirals

…, G Madeddu, CV Martinelli, GV De Socio… - Open forum …, 2017 - academic.oup.com
Weight gain and body mass index (BMI) increase are central issues in patients living with
HIV who need to minimize the risk of metabolic disease. Information collected through the …

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study

GV De Socio, M Pasqualini, E Ricci, P Maggi… - BMC Public Health, 2020 - Springer
Background Tobacco use is a leading cause of preventable diseases and death for all
individuals, even more so for people living with HIV (PLWH), due to their status of chronic …

Factors associated with weight gain in people treated with dolutegravir

…, N Squillace, B Menzaghi, GV De Socio… - Open Forum …, 2020 - academic.oup.com
Background An unexpected excess in weight gain has recently been reported in the course
of dolutegravir (DTG) treatment. The aim of the present study was to investigate whether …

Laboratory Automation, Informatics and Artificial Intelligence: current and future perspectives in clinical microbiology

A Mencacci, GV De Socio, E Pirelli, P Bondi… - Frontiers in Cellular …, 2023 - frontiersin.org
Clinical diagnostic laboratories produce one product – information – and for this to be
valuable, the information must be clinically relevant, accurate, and timely. Although diagnostic …

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large …

…, B Menzaghi, N Squillace, GV De Socio… - BMC Infectious …, 2018 - Springer
Background Dyslipidemia represents a significant non-infectious comorbidity among people
living with HIV. The aim of this study is to evaluate the impact on lipid profile of switches …

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study

GV De Socio, E Ricci, G Parruti, L Calza, P Maggi… - Infection, 2016 - Springer
Objectives To investigate the use of statins and acetylsalicylic acid (ASA) in HIV people in
clinical practice. Design A multicenter, nationwide, prospective cohort study, including 1182 …

Causes of HIV treatment interruption during the last 20 years: a multi-cohort real-life study

…, CV Martinelli, N Squillace, L Taramasso, GV De Socio… - Viruses, 2023 - mdpi.com
In the last years, many antiretroviral drugs (ART) have been developed with increased
efficacy. Nowadays, the main reasons for treatment switches are adverse events, proactive …